Medical Ventures Corp. (TSXV: MEV), a medical devices company specializing in products for the vascular and surgical markets, has received a medical device license from Health Canada for its Metricath Gemini® vessel measurement system.
Canadian licensing permits Medical Ventures to market and sell the device in Canada for use in angioplasty procedures that treat diseased coronary arteries. The license also grants the product country-of-origin certification, a frequent requirement in seeking broader international regulatory acceptance.
The Metricath Gemini device was approved in Europe in Q3 2006 for all vascular applications and is cleared for use in peripheral (non-coronary) artery procedures in the United States. Medical Ventures is presently engaged in a clinical trial - called "GAAME" - to support its application to the U.S. Food & Drug Administration for the device to be used in the U.S. in coronary arteries.
The Metricath Gemini consists of a dual-balloon catheter and electronic console unit. The device's low-pressure balloon measures the internal diameter and area of blood vessels and stents, small expandable mesh tubes placed in damaged arteries to help restore blood flow. The Gemini's high-pressure angioplasty balloon can be used to enlarge vessels or under-deployed stents by expanding the balloon within the artery.
Studies suggest accurately measuring arteries and confirming proper stent deployment during angioplasty can reduce a patient's likelihood of post-procedure complications, including re-narrowing of vessels and/or blood clotting. The Gemini device uniquely allows doctors to measure and treat diseased arteries with a single catheter.
About Medical Ventures Corp.
Medical Ventures Corp. is a medical device company dedicated to developing products that address clinical needs in the quickly growing vascular and surgical marketplace. MEV products help doctors treat a wide range of health concerns, including cardiovascular disease, hernias and obesity. The company develops and manufactures the patented Metricath® System catheter technology and PeriPatch™, a suite of surgical tissue products. Medical Ventures is also a contract medical devices manufacturer. For more information, please visit medical-ventures.
Medical Ventures Corp.
13700 Mayfield Place
Suite 2135 Richmond
BC V6V 2E4 Canada
Phone: 604-270-4344
Fax: 604-270-4384
medical-ventures
Statements contained herein that are not based on historical or current fact, including without limitation statements containing the words "anticipates," "believes," "may," "continues," "estimates," "expects," and "will" and words of similar import, constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, among others, the following: general economic and business conditions, both nationally and in the regions in which the Company operates; technology changes; competition; changes in business strategy or development plans; the ability to attract and retain qualified personnel; existing governmental regulations and changes in, or the failure to comply with, governmental regulations; liability and other claims asserted against the Company; and other factors referenced in the Company's filings with Canadian securities regulators. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company does not assume the obligation to update any forward-looking statements.